On May 21, 2020 Synlogic (Nasdaq: SYBX) reported that the company will host a Virtual R&D Event at 12:30 pm ET on Wednesday, May 27th, 2020 (Press release, Synlogic, MAY 21, 2020, View Source [SID1234558394]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will provide an in-depth review of Synlogic’s Synthetic Biotic platform and programs for the treatment of metabolic diseases inflammatory and immune disorders, and cancer. In addition, guest speaker David S. Goldfarb, M.D., Professor of Medicine and Physiology, NYU School of Medicine, Clinical Chief, Nephrology Division, NYU Langone Health, Chief, Nephrology Section, New York VA Medical Center, will present an overview of enteric hyperoxaluria and a patient perspective.

Registration information for the event can be accessed under "Event Calendar" in the Investors & Media section of the Synlogic website. An archived copy of the webcast will be available on the Synlogic website approximately two hours after the event concludes.